Alzheimer’s Drug Discovery Foundation’s-Open RFPs-Clinical Trials

Objecte

BIOMARKER-BASED TARGET ENGAGEMENT STUDIES to SUPPORT CLINICAL DEVELOPMENT of NOVEL THERAPEUTICS for ALZHEIMER’S DISEASE RFP: The Alzheimer’s Drug Discovery Foundation (ADDF) and the Alzheimer’s Disease Cooperative Study (ADCS) are collaborating to support pilot biomarker-based clinical trials of novel therapeutics for Alzheimer’s disease.

Termini IISPV

Deadline for Receipt of LOI IISPV: 08/29/2014 (europa@iispv.cat)

Termini Oficial

Deadline for Receipt of LOI: September 5, 2014

Estàs interessat?

Omple el següent formulari per rebre més informació: